UP

Cancer immunotherapy drug 'less toxic and prolongs life'

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

An immunotherapy drug that could save some cancer patients from the ordeal of extreme chemotherapy may also help them live longer, researchers say.

Axar.az reports citing BBC.

In a trial, pembrolizumab kept head and neck cancers at bay for an average of two years - five times longer than under chemotherapy.

The patients also suffered far fewer side-effects.

Cases of head and neck cancers are rising in the UK and most are diagnosed late, when they are hard to treat.

Date
2019.11.23 / 21:56
Author
Axar.az
See also

Scientists discover new coronavirus

Azerbaijan performs first deceased donor organ transplants

Fifty countries affected by USAID freeze - WHO

Monkeypox case confirmed in Azerbaijan

WHO calls for international support to fund aid in Gaza

30 metapneumovirus cases reported in Kazakhstan

Human metapneumovirus epidemic reported in China

WHO marks 5 years of COVID-19 and ongoing efforts

Expert warns of public health emergency in Delhi

Gaza polio vaccinations resume after clinic strike

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla